Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H17Cl3N4O4 |
InChIKeyBZXLHTMMVVPPAF-UHFFFAOYSA-N |
CAS Registry868962-26-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 2 | BE | 23 Aug 2007 |